PARTENAR-IA — CQDM — Academic
QC, Canada
Funding for Quebec biopharmaceutical R&D collaborations in AI
grant_single_labels|summary
grant_single|eligibleFinancing
- grant_single|maxCount
- grant_single|projectCostPercent
grant_single|deadlines
- grant_single|openingDateApril 15, 2025
grant_single|financingType
Grant and Funding
grant_single|eligibleIndustries
- Health care and social assistance
grant_single|grantors
- Quebec Consortium for Drug Discovery (CQDM)
grant_single|status
grant_card_status|open
grant_single_labels|preview
<p>Get a non-refundable grant up to $500,000 to cover up to 40% of eligible expenses when your SME partners with a research centre on an artificial intelligence project that accelerates drug discoveries.</p>
grant_single_labels|terms_and_conditions
This grant offers structured financing modalities designed to support collaborative biopharmaceutical R&D projects using artificial intelligence in Quebec. The financing is carefully determined to align with project scale and partnership dynamics.
- Maximum support rate is up to 50% of eligible expenses for both the business and the research institution involved.
- Financial support is capped at $350,000 per eligible partner business, with a total possible allocation of $1,500,000 for a project with five businesses.
- For projects involving two businesses, the maximum grant available is $700,000, contingent on the project's total value not exceeding $1.4 million.
- The project must secure a minimal industrial contribution of 25%, either in cash or in kind, from the participating businesses.
grant_single_labels|projects
This grant is designed to support biopharmaceutical R&D projects in Quebec that leverage artificial intelligence through collaborative efforts. It fosters partnerships between businesses, particularly SMEs, and research institutions to advance innovation.
- Collaborative R&D projects using artificial intelligence between multiple Quebec-based businesses and research institutions.
grant_single|admissibleProjectsExample
$ 220,000
AI algorithm development for neurodegenerative disease drug research
$ 196,000
Using AI to optimize drug formulation processes for oncology
$ 220,000
AI-enhanced cardiovascular drug development project
$ 200,000
Leveraging AI to accelerate antibiotic resistance research
$ 180,000
Developing AI for drug interaction predictions in a lab setting
$ 180,000
Creating an AI-driven platform for rare disease drug discovery
grant_single_labels|admissibility
Eligibility for the Partenar-IA grant is determined by specific requirements that firms must meet to qualify.
- The project must involve a minimum of two businesses conducting R&D or production activities in Quebec.
- At least one of the participating businesses must be a small or medium-sized enterprise (SME) with at least 250 employees.
- The project must be carried out in collaboration with one or several research institutions in Quebec, ensuring at least 20% of the project's involvement is with these institutions, such as universities, hospitals, CCTTs, or public research centers.
- Each participating business is required to hire at least one intern per year for the duration of the project.
- The project must demonstrate a minimal industrial contribution of 25%, which can be in cash and/or in kind.
- External funding from non-MEIE sources can cover, at most, 25% of the project's funding arrangement.
- The project should have a maximum duration of 2 years.
grant_eligibility_criteria|who_can_apply
This grant supports collaborative R&D projects in biopharmaceuticals using AI by businesses in Quebec.
- Collaborative projects between at least two businesses involved in biopharmaceutical R&D in Quebec, with participation from research institutions.
- Involvement of at least one SME with a minimum of 250 employees based in Quebec.
- Commitment to hire at least one intern per year throughout the project duration.
- Requirement for a minimum industrial contribution of 25% towards the project, either in cash or in kind.
- Projects receiving funding from other non-MEIE sources, capped at 25% of the total funding arrangement.
- Projects should have a maximum duration of 2 years.
grant_eligibility_criteria|who_cannot_apply
Some companies may not be eligible for this grant due to specific exclusion criteria. For example, companies involved in tobacco, alcohol, or adult entertainment industries might not qualify.
- Companies engaged in illegal activities.
- Non-profit organizations.
- Companies not registered or operating in Canada.
- Government entities or agencies.
grant_eligibility_criteria|eligible_expenses
Partenar-IA grant is designed to support collaborative R&D projects in the biopharmaceutical sector in Quebec utilizing artificial intelligence. The program aims to foster collaboration between businesses and research institutions to advance technological innovations.
- Collaborative R&D projects involving AI applications in biopharmaceutical processes.
- Innovative projects enhancing drug discovery and development through machine learning and data analytics.
- Integration of AI technologies for improving healthcare outcomes and biomanufacturing efficiency.
- Initiatives involving interdisciplinary teams from industries and academic institutions.
- Projects contributing to the advancement of personalized medicine through AI-driven insights.
grant_eligibility_criteria|zone
This grant is targeted towards businesses conducting activities in Quebec, reflecting regional development priorities and collaboration goals.
- Businesses with R&D or production activities within Quebec.
grant_single_labels|criteria
There are evaluation and selection criteria for this grant. The criteria include but are not limited to the applicant's innovation level, impact on the community, and financial viability.
- Applicant's innovation level
- Impact on the community
- Financial viability
grant_single_labels|register
Here are the steps to submit an application for this grant:
- Step 1: Preliminary Inquiry and Guidance
- Contact Mathieu Paquette via email at mpaquette@cqdm.org to discuss the project and express your interest in applying.
- Obtain any necessary details or clarifications regarding the application process and eligibility.
- Step 2: Gather Required Documentation
- Collect and prepare all necessary documents, including proof of collaborative partnerships with research institutions and evidence supporting eligibility criteria.
- Prepare a detailed project plan highlighting the use of artificial intelligence in biopharmaceutical R&D.
- Compile budget details and outline industrial contributions and other funding arrangements.
- Step 3: Complete Application Form
- Access the official application form provided in the Information Guide.
- Accurately complete all sections of the form, ensuring all data is precise and adheres to the specified guidelines.
- Step 4: Submit Application
- Review the entire application package to ensure completeness and adherence to requirements.
- Submit the full application package, including the completed form and all supporting documents, before the deadline.
- Step 5: Receive Confirmation
- Await a confirmation email acknowledging receipt of the application.
- Ensure to keep a copy of the confirmation for future reference or follow-up.
grant_single_labels|otherInfo
Here are additional relevant details for this grant:
- Strong emphasis is placed on cross-sector collaboration between businesses and research institutions.
- Successful applicants may receive guidance and support from the grant provider throughout the project duration.
- The program aims to strengthen Quebec's position in the biopharmaceutical and AI sectors.
- Projects should demonstrate potential for significant advancements or innovations in biopharmaceutical applications.
grant_single_labels|contact
mpaquette@cqdm.org